Olympus has received FDA 510(k) clearance for its Articulating HD 3D Laparoscopic Surgical Video System, which it claims is the first of its kind and comes armed with data to suggest it improves surgical accuracy, speed and precision.
Olympus is undoubtedly one of the companies considered a pioneer of laparoscopic surgery. Its new Olympus HD 3D video platform is available as a module that can be added to an existing Olympus EVIS EXERA III Universal Imaging System. The modular design reduces the investment necessary to add 3D capability, and allows the surgeon to choose either 2D or 3D visualization from the surgical field.
Olympus boldly claims its Articulating HD 3D Laparoscopic Surgical Video System reduces surgical errors. Internal company testing conducted using a simulated surgical model suggests that using the system improves the speed, accuracy and precision of surgical tasks such as dissection, grasping and suturing when compared with traditional 2D surgical systems.
Dr. Marcos Michellotti, Assistant Professor of Surgery at Loma Linda University Health System in Loma Linda, California states ; “The Olympus HD 3D system is ideal for suturing, accurately identifying tissue planes and other precision surgical tasks that are required in my laparoscopic surgical cases. In addition, the articulating design enables me to obtain the critical view of anatomical structures in HD 3D without losing the important visual horizon. This is not possible with traditional fixed angle laparoscopes”.
“The Olympus HD 3D System brings value to those surgeons that need the precision, resolution, and depth perception of 3D without the substantial capital investment and annual maintenance expenses associated with alternatives such as robotic technology,” said Luke Calcraft, President of the Medical Systems Group at Olympus Corporation of the Americas. “We are leading the way with innovations to help our customers realize the clinical efficacy and cost effectiveness required under Accountable Care.”